On May 13, 2022, the Board of ClearPoint Neuro, Inc. reconstituted its committees. Currently, the Audit Committee consists of Pascal E.R. Girin, as chair, Lynnette C. Fallon and R. John Fletcher, the Compensation Committee consists of B. Kristine Johnson as chair, and Timothy T. Richards, and the Corporate Governance and Nominating Committee consists of Timothy T. Richards, as chair, Lynnette C. Fallon, R. John Fletcher and Pascal E.R. Girin.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.06 USD | -0.16% | -5.31% | -10.75% |
05-07 | ClearPoint Neuro, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | Earnings Flash (CLPT) CLEARPOINT NEURO Reports Q1 Revenue $7.6M, vs. Street Est of $7M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.75% | 166M | |
+11.31% | 225B | |
+15.50% | 197B | |
+18.83% | 143B | |
+30.38% | 111B | |
+2.62% | 64.72B | |
+18.31% | 54.44B | |
+4.96% | 51.06B | |
+9.95% | 45.03B | |
+4.27% | 37.4B |
- Stock Market
- Equities
- CLPT Stock
- News ClearPoint Neuro, Inc.
- ClearPoint Neuro, Inc. Reconstitutes its Committees